Taspoglutide (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Taspoglutide" in English language version.

refsWebsite

Global rank English rank

2web.archive.org

1^st place

1^st place

2medicalnewstoday.com

3,011^th place

2,709^th place

2clinicaltrials.gov

5,225^th place

4,062^nd place

1findarticles.com

424^th place

310^th place

1bio-medicine.org

low place

low place

719^th place

636^th place

1genengnews.com

low place

6,625^th place

1medpagetoday.com

9,274^th place

5,856^th place

bio-medicine.org

"Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials". June 2008. Archived from the original on 3 March 2016. Retrieved 13 January 2009.

clinicaltrials.gov

Clinical trial number NCT01051011 for "A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy" at ClinicalTrials.gov
Clinical studies of taspoglutide

findarticles.com

"Ipsen: Roche Moves Investigational Diabetes Drug, Taspoglutide, into Phase III Clinical Trials". Business Wire. June 2008.

genengnews.com

"Roche Reports Positive Data from Five Phase III Trials of Type 2 Diabetes Therapy". February 2010.

medicalnewstoday.com

"Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint in the First Phase III Clinical Trial". October 2009. Archived from the original on 1 March 2010. Retrieved 12 February 2010.
"Experimental Diabetes Drug Taspoglutide Late-Stage Trials Suspended". 13 September 2010.

medpagetoday.com

"Roche Halts Trials of Taspoglutide". 13 September 2010.

medscape.com

Baggio LL, Drucker DJ (2008). "Glucagon-like Peptide-1 Analogs Other Than Exenatide".

web.archive.org

"Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials". June 2008. Archived from the original on 3 March 2016. Retrieved 13 January 2009.
"Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint in the First Phase III Clinical Trial". October 2009. Archived from the original on 1 March 2010. Retrieved 12 February 2010.